InvestorsHub Logo
Followers 93
Posts 21466
Boards Moderated 0
Alias Born 06/07/2011

Re: 1234jklm post# 69166

Sunday, 05/28/2017 11:41:21 AM

Sunday, May 28, 2017 11:41:21 AM

Post# of 144813
Do you have any facts to prove that?

Yeah right, medical researchers in the academic world never offer to consult for money. You believe they do it for FREE?

Do you know the doctors concerned?



Do you?

So none of the eminent doctors and professors have any integrity



There's no sin for a doctor or professor to offer their consulting services to whomever wishes to pay them.

Have you met Professor Simpson?...Are you really able to say this about her?



Ah, a diversion from Makowka to Simpson. Are we to do this for each one?

Who owns patent US20160244733 for the Melligen cells? Answer: University of Technology Sydney. Simpson listed as a co-inventor.

Who owns the patent combining Melligen cells with CIAB? Answer: None found. CIAB patent expired.

Oh, but they have a license from UTS to use the cells in CIAB. What do we know of the partnership agreement announced back in Jun 2015?

PharmaCyte Biotech and UTS have signed a research services agreement and a consulting contract. The agreement is designed to fund pivotal studies by Professor Ann Simpson, Ph.D. and colleagues to conduct, with the goal of helping fully characterize the parameters by which Melligen cells produce insulin on-demand when encapsulated using Cell-in-a-Box.

The consulting contract is intended to allow Dr. Simpson to devote sufficient time to working with PharmaCyte Biotech and its international Diabetes Consortium as it pursues development of the company’s diabetes treatment.



Wonder how Annie's research is coming along... The last research article she co-authored on Melligen cells was published in the "Molecular Therapy Methods Clinical Development" Journal, 08-Apr-2015. Where the UTS folks injected the Melligen cells directly into rats. This article was published before the partnership announcement with PMCB, and did not involve any CIABs. There's no further articles authored by her in the public domain. Ok, how about searching for research articles with "Melligen diabetes" - the same article pops up as the only hit. How about searching with "PharmaCyte diabetes" - no hits.

So here ya bee, 2 yrs later, and Annie hasn't published anything since 2015. In fact there is nothing published in the scientific journals with the word "PharmaCyte". Which means no one has used CIAB in their research, else they would've noted PMCB as the source. Or they used CIAB, and failed to get a positive result, which could be published.

Butt but but it's a secret! Well, no it isn't. It's called pre-clinical, and without published research, it goes nowhere with the FDA. So whatever happened to the pre-clinical, and drug trials involving Melligen calles +CIAB, PMCB jabbered about in the Aug 2015 10Q?

What we know 2 yrs later is that neither Annie, or anyone else published successful Melligen+CIAB results. The only thing that came out of the so called partnership is that PMCB got a few PR pumps.




The Jewel of the Mind is Colored with the Hue of what it Imagines

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News